Key facts
- Curium announced a strategic investment of over €32 million.
- The investment is directed towards the Saclay, France facility.
- The investment aims to expand operations and capabilities.
Curium is a global radiopharmaceutical company. This investment in its French facility signifies a commitment to expanding its European presence and capabilities in the production and development of radiopharmaceuticals, which are crucial for medical imaging and treatment.